MicroCHIPS (Bedford, MA) a development-stage medical device company focused on implantable drug delivery and biosensing for diabetes and osteoporosis, closed a $16.5M Series C financing. Participants include InterWest Partners, Polaris Venture Partners, Novartis Venture Fund, Flybridge Capital Partners, Medtronic, Saints Capital, Intersouth Partners, Care Capital and CSK Venture Capital.

Tandem Diabetes Care (San Diego, CA) a development-stage medical device company focused on insulin pump technology, closed a $30.8M Series C financing, bringing the total round to $52.3M. Participants include HLM Venture Partners, Domain Associates, TPG Biotech, Delphi Ventures and Kearny Venture Partners.

CeQur (Switzerland) a development-stage device company focused on a wearable insulin infuser for the continuous subcutaneous delivery of insulin for Type II diabetes, closed a $29.6M Series A financing. Participants include BMC Ventures, Endeavour Vision, Schroders and Venture Incubator.

Intuity Medical (Sunnyvale, CA) a clinical-stage diagnostic device company focused on all-in-one blood sample collection and glucose analysis, closed a Series D financing. Participants include Venrock, Emergent Medical Partners, Investor Growth Capital, Thomas McNerney and Partners, U.S. Venture Partners and Versant Ventures.

Tethys Bioscience (Emeryville, CA) a commercial-stage diagnostics company focused on type II diabetes risk assessment through the measurement of multiple biomarkers, closed a $25M Series D financing. Participants include Capital AG, Wasatch Advisors, Mohr Davidow Ventures, Kleiner Perkins Caulfield & Byers and Intel Capital.
Note: 2009 Year-in-Review Trend Analysis Coming 15 Feb

MetaCure (Orangeburg, NY) a clinical-stage device company focused on the treatment of adult type II diabetes via an implantable pulse generator delivering electrical stimulation via gastric contractility modulation, closed a $20M Series B financing. Participants include the Morningside Group.

ArKal Medical (Fremont, CA) developer of a continuous glucose monitoring system, closed a $17.5M Series B financing. Participants include Thomas McNerney & Partners, Delphi Ventures and MedVenture Associates.

Calibra Medical (Seattle, WA) development-stage medical device company focused on insulin delivery solutions, closed a $35M Series B financing. Participants include Canaan Partners, InterSouth Partners, Skyline Ventures, Frazier Healthcare Ventures, and Three Arch Partners.

GluMetrics (Irvine, CA) development-stage medical device company focused on glucose monitoring devices, closed a $20.1M Series C financing. Participants include New Leaf Venture Partners, Versant Ventures and Advanced Technology Ventures.

Tandem Diabetes Care (San Diego, CA) focused on medical devices for diabetes closed a $13.1 Series B financing. Participants include Domain Associates, TPG Biotech and Second Technology Capital Investors.